SCHEMBL4636265

SCHEMBL4636265

CCc1nc(-c2ccc(F)cc2)ncc1C(=O)O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MAPT P10636 5/20 0.45
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
LMNA P02545 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45
CYP2C19 P33261 2/20 0.45
GABRP O00591 1/20 0.44
GABRD O14764 1/20 0.44
GABRA1 P14867 1/20 0.44
GABRB1 P18505 1/20 0.44
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6737103 0.84 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL9650472 0.83 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL9650494 0.81 NPC1 (0.75) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL4384415 0.81 SMN1; SMN2 (0.63) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL22573586 0.78 NPC1 (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL9649535 0.77 LMNA (0.51) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL5014341 0.74 KDM4E (0.42) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL5014336 0.72 FOS (0.60) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL18539734 0.72 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E
SCHEMBL15718403 0.72 GABRP (0.50) ALDH1A1SMN1; SMN2NPC1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1937652-B1 PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS AVENTIS PHARMA INC (US) 2014-07-30 EP disclosed
EP-1937652-A1 PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS Aventis Pharmaceuticals Inc. (US) 2008-07-02 EP disclosed
WO-2007041634-A1 PYRIMIDINE AMIDE COMPOUNDS AS PGDS INHIBITORS AVENTIS PHARMACEUTICALS INC. (US) 2007-04-12 WO disclosed